344 Utilization of glucagon-like peptide-1 receptor agonist at the time of total hip arthroplasty for patients with morbid obesity

e006 Operating Room Size Does Not Affect Periprosthetic Joint Infection Risk for Primary Hip and Knee Arthroplasty